Contains fulltext : 199453.pdf (publisher's version ) (Closed access)OBJECTIVE: We investigated system-level corticostriatal changes in a human model of premotor Parkinson disease (PD), i.e., healthy carriers of the G2019S LRRK2 mutation that is associated with a markedly increased, age-dependent risk of developing PD. METHODS: We compared 37 asymptomatic LRRK2 G2019S mutation carriers (age range 30-78 years) with 32 matched, asymptomatic nonmutation carriers (age range 30-74 years). Using fMRI, we tested the hypothesis that corticostriatal connectivity in premotor PD shifts from severely affected to less affected striatal subregions, as shown previously in symptomatic PD. Specifically, we predicted that in premotor PD, th...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
International audienceBackground: Subthalamic nucleus deep brain stimulation (STN-DBS) has demonstra...
Contains fulltext : 89190.pdf (publisher's version ) (Open Access)Parkinson's dise...
OBJECTIVE: We investigated system-level corticostriatal changes in a human model of premotor Parkins...
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) can cause Parkinson's disease (P...
Objectives: A mutation in leucine-rich repeat kinase 2 is the most common cause of hereditary Parkin...
In Parkinson’s disease (PD), there are alterations of the basal ganglia (BG) thalamocorti-cal networ...
Contains fulltext : 89191.pdf (publisher's version ) (Open Access)Parkinson's dise...
Contains fulltext : 170326.pdf (publisher's version ) (Closed access)Mutations in ...
INTRODUCTION: The G2019S mutation in the leucine rich repeat kinase 2 (LRRK2) gene is prevalent amon...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Contains fulltext : 167889.pdf (publisher's version ) (Closed access)Cognitive imp...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Background: Glucosylceramidase (GBA) mutations are considered the most common genetic risk factors f...
Objective: Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor for de...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
International audienceBackground: Subthalamic nucleus deep brain stimulation (STN-DBS) has demonstra...
Contains fulltext : 89190.pdf (publisher's version ) (Open Access)Parkinson's dise...
OBJECTIVE: We investigated system-level corticostriatal changes in a human model of premotor Parkins...
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) can cause Parkinson's disease (P...
Objectives: A mutation in leucine-rich repeat kinase 2 is the most common cause of hereditary Parkin...
In Parkinson’s disease (PD), there are alterations of the basal ganglia (BG) thalamocorti-cal networ...
Contains fulltext : 89191.pdf (publisher's version ) (Open Access)Parkinson's dise...
Contains fulltext : 170326.pdf (publisher's version ) (Closed access)Mutations in ...
INTRODUCTION: The G2019S mutation in the leucine rich repeat kinase 2 (LRRK2) gene is prevalent amon...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Contains fulltext : 167889.pdf (publisher's version ) (Closed access)Cognitive imp...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Background: Glucosylceramidase (GBA) mutations are considered the most common genetic risk factors f...
Objective: Mutations in the glucocerebrosidase gene (GBA) represent a significant risk factor for de...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
International audienceBackground: Subthalamic nucleus deep brain stimulation (STN-DBS) has demonstra...
Contains fulltext : 89190.pdf (publisher's version ) (Open Access)Parkinson's dise...